Biopharmaceutical Oral Drug Delivery Market Overview
Biopharmaceuticals are the drugs produced by using biotechnology. Biopharmaceutical products are normally protein (antibodies), nucleic acids (DNA, RNA or oligonucleotides). They are used for therapeutic and in-vivo diagnostic purpose. Biopharmaceutical substances are derived from the life forms. It is fastest growing segment of the pharmaceutical market. At the moment, biopharmaceuticals are generally delivered by intravenous or subcutaneous injection. This way of administration is effective but not desired by patients especially in the case of chronic disease. Oral drug delivery is the most preferred route of drug administration. Oral drug delivery route is convenient and easy to use. Even though oral drug delivery of biopharmaceutical bring as many advantages as challenges since it shows several barriers like, pH variations, enzymes, tights junctions, electrolytes, water and food effect which limit the absorption of biopharmaceuticals.
Biopharmaceutical Oral Drug Delivery Market: Drivers and Restraints
Safety and efficacy associated with the biopharmaceutical products are the factors driving the growth of this market. Biopharmaceutical can also treat diseases which were previously untreatable due to targeted delivery. Biopharmaceutical oral drug delivery market will be driven by patient compliance of these products. But there remain challenges of bioavailability of these products if given orally. If biopharmaceutical drugs are given orally, they will be degraded by enzymes and acidic environment in stomach and GI. These products cannot cross epithelial barrier of small intestine due to the large size of their molecules. Due to these factors bioavailability of orally induced biopharmaceuticals decreases. The high cost associated with the biopharmaceutical substances is also a restraint for the growth of biopharmaceutical oral drug delivery market
Biopharmaceutical Oral Drug Delivery Market: Overview
Biopharmaceutical oral drug delivery market is expected to show significant growth. Patient’s preference for less invasive route of administration is expected to drive the growth of biopharmaceutical oral drug delivery market. Development of various technology such as Gastrointestinal Permeation Enhancement Technology, Eligen, Oral Antibody Platform and others, facilitating the oral drug delivery and increasing bioavailability will be factors for the growth of this market. Safety & efficacy and capability of these agents to target specific disease will boost the growth of biopharmaceutical market. The focus of pharmaceutical companies towards biotechnology, development of biopharmaceutical products is expected to drive the growth of biopharmaceutical oral drug delivery market. Biopharmaceutical market is expected to be benefited by entry of the new players with innovative technology.
Biopharmaceutical Oral Drug Delivery Market: Region Wise Outlook
Geographically biopharmaceutical oral drug delivery market can be segmented into North America, Latin America, Eastern Europe, Western Europe, Asia-Pacific excluding Japan, Japan and the Middle East and Africa. North America and Europe are expected to be the biggest market for biopharmaceutical oral drug delivery segment. Availability of key players, better research & development facilities and better reimbursement policies are the factors driving the growth of this market. Increasing prevalence of life-style diseases are also expected to drive the growth of biopharmaceutical market in this region. Asia Pacific market is expected to be fastest growing segment especially India due to the presence of major market players and increasing need for personalized medicines. Increasing focus of companies on biopharmaceuticals products is fueling the growth of biopharmaceutical oral drug delivery market.
Biopharmaceutical Oral Drug Delivery Market: Key Players
Some of the market participants in the global biopharmaceutical oral drug delivery market are AbbVie, Inc., Amgen, Inc., Catalent Inc, Kemwell Bipharma., Pfizer, Inc., Novartis AG, Biocon, Sanofi, F. Hoffman-La Roche Ltd., and Novo Nordisk A/S. These companies are focusing on the development of technology which will improve the bioavailability of orally induced biopharmaceutical products. They are also focusing on research and development for the targeted drug delivery. Key players are using merger & acquisition and collaboration strategies to increase their presence in the biopharmaceutical market.
The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geographies, application, and industry.
The report covers exhaust analysis on:
- Market Segments
- Market Dynamics
- Market Size
- Supply & Demand
- Current Trends/Issues/Challenges
- Competition & Companies involved
- Value Chain
Regional analysis includes:
- North America (U.S., Canada)
- Latin America (Mexico. Brazil)
- Western Europe (Germany, Italy, France, U.K, Spain)
- Eastern Europe (Poland, Russia)
- Asia Pacific (China, India, ASEAN, Australia & New Zealand)
- Middle East and Africa (GCC Countries, S. Africa, Northern Africa)
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
Biopharmaceutical Oral Drug Delivery Market: Segmentation
Biopharmaceutical oral drug delivery market can be segmented on the basis of distribution channel and region.
On the basis of distribution channel biopharmaceutical oral drug delivery market can be segmented into:
- Hospital Pharmacy
- Retail Pharmacy
- Specialty Pharmacy
- Detailed overview of parent market
- Changing market dynamics in the industry
- In-depth market segmentation
- Historical, current and projected market size in terms of volume and value
- Recent industry trends and developments
- Competitive landscape
- Strategies of key players and products offered
- Potential and niche segments, geographical regions exhibiting promising growth
- A neutral perspective on market performance
- Must-have information for market players to sustain and enhance their market footprint
Market Research Methodology - Perfected through Years of Diligence
A key factor for our unrivaled market research accuracy is our expert- and data-driven research methodologies. We combine an eclectic mix of experience, analytics, machine learning, and data science to develop research methodologies that result in a multi-dimensional, yet realistic analysis of a market.